Exploration and validation of a novel reactive oxygen species–related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer

Exploration and validation of a novel reactive oxygen species–related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer

BackgroundReactive Oxygen Species (ROS), a hallmark of cancer, is related to prognosis, tumor progression, and treatment response. Nevertheless, the correlation of ROS-based molecular signature with clinical outcome and immune cell infiltration has not been thoroughly studied in bladder cancer (BLCA...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yulei Li, Lulu Zhang, Gang Xu, Jiajun Chen, Keyuan Zhao, Mengyao Li, Jing Jin, Chao Peng, Kaifang Wang, Shouhua Pan, Ke Zhu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Immunology
Subjects:	bladder cancer reactive oxygen species prognostic signature chemotherapy response overall survival AKR1B1
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1493528/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification and validation of the nicotine metabolism-related signature of bladder cancer by bioinformatics and machine learning
by: Yating Zhan, et al.
Published: (2024-12-01)

Aldo-keto reductase family 1 member B10 prevents esophageal squamous cell carcinoma from reactive carbonyl species-induced cell death and promotes its progression
by: Shau-Hsuan Li, et al.
Published: (2024-12-01)

Identification of inflammation related gene signatures for bladder cancer prognosis prediction
by: Yonggui Xiao, et al.
Published: (2024-11-01)

Prognostic role of prognostic nutritional index in patients with bladder cancer: a systematic review and meta-analysis
by: Jing Sun, et al.
Published: (2025-01-01)

Fatty acid metabolism-related signature suggests an oncogenic role of TEKT1 in endometrial cancer
by: Zhikai Xiahou, et al.
Published: (2025-01-01)

Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets
by: Ganfei Xu, et al.
Published: (2024-12-01)

MYC inhibits migration of lung cancer cell lines by down-regulating AKR1C1 expression
by: JIA Kun, ZHOU Yanyan
Published: (2024-12-01)

AKR1C1 interacts with STAT3 to increase intracellular glutathione and confers resistance to oxaliplatin in colorectal cancer
by: Zhiwen Fu, et al.
Published: (2024-12-01)

Lactylation-related gene signature accurately predicts prognosis and immunotherapy response in gastric cancer
by: Xuezeng Sun, et al.
Published: (2024-11-01)

CDC20 and CCNB1 Overexpression as Prognostic Markers in Bladder Cancer
by: Hatice Sevim Nalkiran, et al.
Published: (2024-12-01)

Identification of pyrimidine metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical treatment in prostate cancer
by: Yu-Zhong Yu, et al.
Published: (2025-12-01)

Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer
by: Chong Shen, et al.
Published: (2025-01-01)

Lipid metabolism subtypes reflects the prognosis and immune profiles of bladder cancer patients by NMF clustering and building related signature
by: Zhongbao Zhou, et al.
Published: (2024-12-01)

Development of a prognostic gene signature and exploration of P4HA1 in the modulation of cuproptosis in colorectal cancer
by: RenJie Jiang, et al.
Published: (2024-12-01)

The pan-cancer landscape of aldo-keto reductase1B10 reveals that its expression is diminished in gastric cancer
by: Anqi Wu, et al.
Published: (2024-12-01)

Prognostic signature based on mitochondria- and angiogenesis-related genes associated with immune microenvironment of multiple myeloma
by: Dai Zhang, et al.
Published: (2025-12-01)

AKRs confer oligodendrocytes resistance to differentiation-stimulated ferroptosis
by: Valentina Saverio, et al.
Published: (2025-02-01)

AKR1D1*36 C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers – a pilot study in healthy volunteers
by: Kapedanovska Nestorovska Aleksandra, et al.
Published: (2019-09-01)

Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors
by: Mina Cho, et al.
Published: (2024-12-01)

Identification and construction of prognostic clusters and risk-prognosis model based on aging-immune related genes in bladder cancer
by: Nihao Cao, et al.
Published: (2024-12-01)

PACAP/PAC1 regulation in cystitis rats: induction of bladder inflammation cascade leading to bladder dysfunction
by: Hanwei Ke, et al.
Published: (2024-11-01)

AKR1B10 and digestive tumors development: a review
by: Yao Shen, et al.
Published: (2024-12-01)

AKR1C3 mediates gastric cancer cell invasion and metastasis via the AKT and JNK/p-NF-κB signaling pathways
by: Liying Lin, et al.
Published: (2024-12-01)

Brief Warm and Aldo-Keto Reductase Family <i>AspiAKR1B1</i> Contribute to Cold Adaptation of <i>Aleurocanthus spiniferus</i>
by: Zhi-Fei Jia, et al.
Published: (2025-01-01)

Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy
by: Ezgi Değerli, et al.
Published: (2024-12-01)

Identification and validation of glucose metabolism-related gene signature in endometrial cancer
by: Juan Jiang, et al.
Published: (2025-01-01)

Combining immunogenic cell death and cuproptosis to construct a prognostic signature and predict the immune status and treatment efficacy for hepatocellular carcinoma
by: Xin Feng, et al.
Published: (2024-12-01)

A novel histone acetylation-associated gene signature with prognostic value in Ewing sarcoma
by: Anshun Wu, et al.
Published: (2024-12-01)

Integrated singlecell and bulk RNA-seq analysis identifies a prognostic signature related to inflammation in colorectal cancer
by: Wen Yin, et al.
Published: (2025-01-01)

The Importance of Expression of Keratin 17 (KRT17) and SPINK1 in Neoplastic (Invasive and Noninvasive) Lesions of the Bladder
by: İsmail Harmankaya, et al.
Published: (2022-08-01)

The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer
by: M. P. Smal, et al.
Published: (2015-12-01)

Commentary: Construction and validation of prognostic signatures related to mitochondria and macrophage polarization in gastric cancer
by: Bingdi Wei, et al.
Published: (2024-11-01)

Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature
by: Yong Huang, et al.
Published: (2025-01-01)

A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma
by: Sanlin Wei, et al.
Published: (2024-12-01)

Identification of anoikis-related molecular patterns and the novel risk model to predict prognosis, tumor microenvironment infiltration and immunotherapy response in bladder cancer
by: Luochen Zhu, et al.
Published: (2024-11-01)

Comprehensive analysis reveals cholesterol metabolism-related signature for predicting prognosis and guiding individualized treatment of glioma
by: Dengfeng Lu, et al.
Published: (2025-01-01)

Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
by: L. S. Franco, et al.
Published: (2025-01-01)

An overview of immune checkpoint inhibitor toxicities in bladder cancer
by: Avenie Mavadia, et al.
Published: (2024-12-01)

Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC
by: Haotian Qin, et al.
Published: (2025-01-01)

Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC
by: Xia Zhang, et al.
Published: (2024-10-01)